ALBIREO PHARMA, INC. Chart calendar Albireo Pharma, Inc.
d9cb409f20cc148cf.8ISpFbEhpKeFGuqMC3dkr9Z0cdEeZDsB0g55EZm7vP4.hvLqQ-VtnJPHY93WQk4O3pcYMoRzB0pogD0VePXr6pai18h850ud6txIuw~9b7f648e0f439160f1d1a75d87424b97
Upcoming events on Albireo Pharma, Inc.
No events available
Past events on Albireo Pharma, Inc.
| 15/11/2022 10:20 | Jefferies London Healthcare Conference |
| 08/11/2022 21:30 | Q3 2022 Earnings Call |
| 07/11/2022 | Q3 2022 Earnings Release After hours |
| 07/11/2022 18:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37254 |
| 07/11/2022 18:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37608 |
| 07/11/2022 18:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 850 |
| 07/11/2022 18:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37939 |
| 07/11/2022 18:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37273 |
| 06/11/2022 19:10 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 865 |
| 06/11/2022 18:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Meeting : 37733 |
| 18/10/2022 15:30 | H.C. Wainwright Hepatitis B Virus (HBV) Conference |
| 15/10/2022 19:00 | NASPGHAN Meeting |
| 15/10/2022 17:00 | NASPGHAN Meeting - Abstract Number : 547 |
| 14/10/2022 18:45 | NASPGHAN Meeting |
| 14/10/2022 17:00 | NASPGHAN Meeting - Abstract Number : 301 |
| 13/10/2022 22:00 | NASPGHAN Meeting - Abstract Number : 70 |
| 11/10/2022 13:30 | Bylvay Phase 3 Trial Results Call |
| 28/09/2022 13:30 | Guggenheim Therapeutics Conference |
| 13/09/2022 13:30 | Baird Global Healthcare Conference |
| 12/09/2022 15:30 | Morgan Stanley Global Healthcare Conference |
More events
